Immunotherapeutic products, and immune checkpoints inhibitors in particular, are increasingly used in the management of malignancies, both as...
A thorough overview of the four main types of leukemia (acute and chronic myeloid, acute lymphoblastic and chronic lymphocytic), with superb...
The peripheral T-cell lymphomas (PTCLs) are a heterogenous group of rare entities. Whilst cytogenetic and molecular identifiers are being identified...
El uso de inmunoterapia para el tratamiento de neoplasias tanto sólidas como hematológicas es extenso. Los inhibidores del punto de control...
This last year has seen the approval of the first targeted treatments for acute myeloid leukemia (AML) - following decades with no new developments...
Biologics have revolutionized – and are revolutionizing – the treatment of many serious disorders. The evidence acquired from more than 10 years of...
Tuberculosis (TB) remains one of the major infectious diseases of mankind although drugs for its treatment have been available for nearly 60 years...
Under the auspices of the 12th International Symposium on Special Aspects in Radiotherapy 2008 in Berlin, acknowledged experts presented their...
The field of adolescents and young adult (AYA) oncology is experiencing a very challenging time. This book is a guide to the key issues for any...
At present most intracranial gliomas are considered incurable with current treatment strategies, and the search for new modalities that may...